Participate in Research |

17 Apr

REMAIN-1 Weight Loss Study

The purpose of this study is to learn if a one-time, minimally-invasive endoscopic procedure called DMR (duodenal mucosal resurfacing) can help people maintain weight loss after stopping Zepbound, a prescription GLP-1 drug for weight loss. All participants on this study will receive free Zepbound (an FDA-approved...

18 Mar

Tirzepatide in Special Populations

Tirzepatide is an FDA-approved medication for the treatment of obesity. It has proven success for weight management populations with non-syndromic obesity. Special populations such as Prader-Willi Syndrome and Hypothalamic Obesity do not have FDA-approved medications for weight loss. In addition, these special populations have not...

06:24 / *Healthy Volunteer Studies / Food, Nutrition & Metabolism

Quick Links

Tirzepatide Tag

REMAIN-1 Weight Loss Study

Tirzepatide in Special Populations